Drugs / Pf p52(-)/p36(-) GAP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01024686 | Mar 2010 → Jun 2011 | malaria | Seattle Children's Hospital | Terminated | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pf p52(-)/p36(-) GAP | “A first generation Plasmodium falciparum GAP (Pf p52(-)/p36(-) GAP) was previously generated by deletion of two pre-erythrocytic stage-expressed genes (P52 and P36) in the NF54 strain.” PMID 24029408 ↗ Sep 2013 |
| Known as | p52-/p36- GAP vaccine | “p52-/p36- GAP Vaccine: Administered by five bites from GAP-infected Anopheles mosquito” NCT01024686 ↗ |
| Route | Other | “via infected Anopheles mosquito bite” PMID 24029408 ↗ Sep 2013 |
| Target | P36 | “deletion of two pre-erythrocytic stage-expressed genes (P52 and P36)” PMID 24029408 ↗ Sep 2013 |
| Target | P52 | “deletion of two pre-erythrocytic stage-expressed genes (P52 and P36)” PMID 24029408 ↗ Sep 2013 |